Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 20 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia at Risk of Acute Pancreatitis
NCT06880770
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Research Site Los Angeles, California, United States
- Clinical Research Site 4 Santa Clarita, California, United States
- Research Site New Haven, Connecticut, United States
- Clinical Research Site 6 Springfield, Illinois, United States
NCT07269210
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Axsendo Clinical Research - Peak Heart & Vascular - Phoenix Phoenix, Arizona, United States
- Synexus Clinical Research US, Inc./Orange Grove Family Practice Tucson, Arizona, United States
- National Heart Institute Beverly Hills, California, United States
- Ark Clinical Research Long Beach, California, United States
NCT07604974
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Ionis Investigative Site Lincoln, California, United States
- Ionis Investigative Site Aurora, Colorado, United States
- Ionis Investigative Site Boca Raton, Florida, United States
- Ionis Investigative Site Miami, Florida, United States
Not Yet Recruiting
A Phase 3 Trial of DR10624 Versus Placebo in Patients With Severe Hypertriglyceridemia
NCT07680829
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Peking University First Hospital Beijing, China
- Peking University People's Hospital Beijing, China
Completed
To Evaluate the Efficacy and Safety of Pegozafermin in Subjects With Severe Hypertriglyceridemia
NCT05852431
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- 89bio Clinical Study Site Chandler, Arizona, United States
- 89bio Clinical Study Site Peoria, Arizona, United States
- 89Bio Clinical Study Site Tucson, Arizona, United States
- 89bio Clinical Study Site Conway, Arkansas, United States
- Conditions
- Arterial Occlusive Diseases, Arteriosclerosis, Atherosclerosis, +10 more
- Locations
-
- Clinical Trials Research Lincoln, California, United States
- Catalina Research Institute, LLC Montclair, California, United States
- Excel Medical Clinical Trials, LLC Boca Raton, Florida, United States
- De La Cruz Research Center Miami, Florida, United States
NCT04720534
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Research Site 2 Beverly Hills, California, United States
- Research Site 4 Palm Springs, California, United States
- Research Site 5 Boca Raton, Florida, United States
- Research Site 6 Fort Lauderdale, Florida, United States
Completed
A Study of Olezarsen (ISIS 678354) Administered to Participants With Severe Hypertriglyceridemia
NCT05079919
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Accel Research Sites Network Birmingham, Alabama, United States
- Mayo Clinic Scottsdale, Arizona, United States
- Velocity Clinical Research Chula Vista, California, United States
- Diabetes/Lipid Management & Research Center Huntington Beach, California, United States
NCT06555640
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Baoding No.1 Central Hospital Baoding, China
- The First Affiliated Hospital of Baotou Medical College Baotou, China
- Peking University First Hospital Beijing, China
- The First Affiliated Hospital of Bengbu Medical University Bengbu, China
Completed
A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia
NCT05552326
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Central Research Associates, Inc. Birmingham, Alabama, United States
- Alabama Clinical Therapeutics, LLC Alabaster Birmingham, Alabama, United States
- Onyx Clinical Research Peoria, Arizona, United States
- NRC Research Institute Los Angeles, California, United States
NCT04541186
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- 89Bio Clinical Study Site La Mesa, California, United States
- 89Bio Clinical Study Site San Francisco, California, United States
- 89Bio Clinical Study Site Clearwater, Florida, United States
- 89Bio Clinical Study Site Greenacres City, Florida, United States
NCT03001817
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Central Research Associates, Inc. Birmingham, Alabama, United States
- Central Alabama Research Birmingham, Alabama, United States
- Cahaba Research, Inc. Birmingham, Alabama, United States
- Boyett Health Services Inc Hamilton, Alabama, United States
NCT03011450
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Central Research Associates, Inc. Birmingham, Alabama, United States
- Central Alabama Research Birmingham, Alabama, United States
- Cahaba Research, Inc. Birmingham, Alabama, United States
- Boyett Health Services Inc Hamilton, Alabama, United States
NCT02944383
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +5 more
- Locations
-
- Appalachian Research Associates Fort Payne, Alabama, United States
- Del Sol Research Mangagement, LLC Tucson, Arizona, United States
- Westside Medical Associates of Los Angeles Beverly Hills, California, United States
- Hope Clinical Research Canoga Park, California, United States
NCT01242527
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- National City, California, United States
- Sacramento, California, United States
- Manchester, Connecticut, United States
- Coral Gables, Florida, United States
NCT02189252
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Research Site Kansas City, Kansas, United States
- Research Site Cincinnati, Ohio, United States
- Research Site Philadelphia, Pennsylvania, United States
- Research Site Chocoutimi, Quebec, Canada
NCT01208961
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Radiant Research Chicago, Illinois, United States
Active, Not Recruiting
Study of Plozasiran (ARO-APOC3) in Adults With Severe Hypertriglyceridemia
NCT06347003
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Research Center 1 Garden Grove, California, United States
- Research Center 2 Lake Forest, California, United States
- Research Center 3 Montclair, California, United States
- Research Center 4 Panorama City, California, United States
Active, Not Recruiting
CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG)
NCT05681351
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- LA Universal Research Center, Inc. Los Angeles, California, United States
- University of California, San Diego (UCSD) San Diego, California, United States
- Metabolic Institute of America Tarzana, California, United States
- Excel Medical Clinical Trials Boca Raton, Florida, United States
Active, Not Recruiting
Study of Plozasiran in Adults With Severe Hypertriglyceridemia
NCT06347016
- Conditions
- Dyslipidemias, Hyperlipidemias, Hypertriglyceridemia, +4 more
- Locations
-
- Research Site 1 Birmingham, Alabama, United States
- Research Site 2 Mobile, Alabama, United States
- Research Site 3 Beverly Hills, California, United States
- Research Site 4 Canoga Park, California, United States